nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acamprosate Calcium Delayed-Release Tablets
|
Cada, Dennis J. |
|
2004 |
|
12 |
p. 1177-1188 |
artikel |
2 |
Acute Pancreatitis with Isotretinoin; Adrenal Insufficiency Caused by Azole Antifungal; High-Dose Quetiapine and Photopsia; Levamisole and Leukoencephalopathy; Metabolic Syndrome and Clozapine; Increased ADRs to Antimicrobials and Anticonvulsants in AIDS Patients; Unsuspected Trouble with an OTC Medication
|
Shuster, Joel |
|
2006 |
|
12 |
p. 1152-1154 |
artikel |
3 |
Acute Sensorineural Hearing Loss: Furosemide Ototoxicity Revisited
|
Baldwin, Kathleen A. |
|
2008 |
|
12 |
p. 982-988 |
artikel |
4 |
Adopt Health Information Technology Systems Now! But in what Sequence?
|
Felkey, Bill G. |
|
2008 |
|
12 |
p. 1014-1015 |
artikel |
5 |
Advances and Controversies in Adult ICU Sedation, Part 1: An Overview of the Importance of Sedation and Agitation and Subjective Assessment Tools for Patient Evaluation
|
Fraser, Gilles L. |
|
2001 |
|
12 |
p. 1266-1278 |
artikel |
6 |
Adverse Event Reporting and Rofecoxib Withdrawal: Are Postmarketing Changes Imminent?
|
Cada, Dennis J. |
|
2004 |
|
12 |
p. 1138 |
artikel |
7 |
Alternative Medicines in the Hospital Setting
|
Generali, Joyce |
|
2002 |
|
12 |
p. 1256 |
artikel |
8 |
Ambrisentan
|
Cada, Dennis J. |
|
2007 |
|
12 |
p. 1145-1154 |
artikel |
9 |
Anaphylaxis Seen with a Special Dye; •Cholestasis Caused by Cetirizine; •Acarbose and Lymphocytic Colitis; •Seizures Caused by Intravenous Alatrofloxacin; •Pedal Edema Caused by Olanzapine; •Disturbances in Electrolyte Homeostasis as an Adverse Effect of Gentamicin Therapy
|
Shuster, Joel |
|
2000 |
|
12 |
p. 1288-1291 |
artikel |
10 |
Another Purpose for “Purpose” Look-Alike Unit-Dose Containers Mixed up Misinterpretation of Sliding-Scale Insulin Dose
|
Cohen, Michael R. |
|
2001 |
|
12 |
p. 1132-1133 |
artikel |
11 |
Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
|
Baker, Danial E. |
|
2012 |
|
12 |
p. 963-968 |
artikel |
12 |
A Prospective Observational Study of Risk Factors for Candida glabrata in an SICU: Role of Fluconazole
|
Gentry, Chris A. |
|
2007 |
|
12 |
p. 1139-1144 |
artikel |
13 |
A Retrospective Review of Short-Term Outcomes after Switching Patients from Clopidogrel to Alternative Antiplatelet Therapy
|
Fjeldheim, Renae |
|
2009 |
|
12 |
p. 1103-1111 |
artikel |
14 |
A Starting Point for the Year 2000
|
Davis, Neil M. |
|
1999 |
|
12 |
p. 1376 |
artikel |
15 |
Automation of the Medication History Process: A Case Report
|
Weeks, Greg |
|
2005 |
|
12 |
p. 1057-1061 |
artikel |
16 |
Avoiding Plagiarism
|
Joseph, M. LaRochelle |
|
2011 |
|
12 |
p. 917-919 |
artikel |
17 |
Azithromycin-Induced Hepatotoxicity
|
Kim, Mina |
|
2012 |
|
12 |
p. 946-949 |
artikel |
18 |
Basic Bibliographies
|
|
|
1999 |
|
12 |
p. 1481-1486 |
artikel |
19 |
Basic Bibliographies
|
|
|
2000 |
|
12 |
p. 1353-1356 |
artikel |
20 |
Brentuximab Vedotin and Vemurafenib
|
Michael, S. Edwards |
|
2011 |
|
12 |
p. 934-942 |
artikel |
21 |
Carbetolol?
|
Dunn, Eddie B. |
|
2001 |
|
12 |
p. 1303-1304 |
artikel |
22 |
Cephalosporins for Patients with a History of Penicillin Allergy: The Safety of an Oral Test Dose
|
Mamta, Sharma |
|
2011 |
|
12 |
p. 952-955 |
artikel |
23 |
Certolizumab Pegol
|
Cada, Dennis J. |
|
2008 |
|
12 |
p. 998-1010 |
artikel |
24 |
Cholestatic Pruritus: Colesevelam
|
Generali, Joyce A. |
|
2010 |
|
12 |
p. 914-915 |
artikel |
25 |
Clinical Experience with Linezolid at a Large Academic Medical Center: A Case Series and Review of the Literature
|
Heintz, Brett H. |
|
2010 |
|
12 |
p. 916-926 |
artikel |
26 |
Compatibility Screening of Gatifloxacin during Simulated Y-Site Administration with other Drugs
|
Trissel, Lawrence A. |
|
1999 |
|
12 |
p. 1409-1417 |
artikel |
27 |
Complementary and Alternative Medicine: Regulatory Issues and Perspectives
|
Budlong, Lynn |
|
2000 |
|
12 |
p. 1267-1273 |
artikel |
28 |
Considerations for PDA-Based Intervention Documentation
|
Fox, Brent I. |
|
2003 |
|
12 |
p. 1180-1182 |
artikel |
29 |
Contracted Drug Information Services: Comparison of Utilization with Local Hospital Pharmacists
|
Chyka, Peter A. |
|
2000 |
|
12 |
p. 1304-1307 |
artikel |
30 |
Correctional Facilities: Health Care and Pharmacy, Part 1 Bibliography Index
|
|
|
2004 |
|
12 |
p. 1208-1211 |
artikel |
31 |
Cotrimoxazole and Wegener's Granulomatosis
|
Burnakis, Thomas G. |
|
1999 |
|
12 |
p. 1475-1477 |
artikel |
32 |
CVP (Cyclophosphamide, Vincristine, and Prednisone) Regimen for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphomas
|
Kem, Ravie |
|
2003 |
|
12 |
p. 1126-1133 |
artikel |
33 |
Dabigatran-lnduced Rash/Type B Lactic Acidosis Associated with Carboplatin Therapy/Sunitinib-Induced Hyperammonemic Encephalopathy/Virilization from Partner's Use of Topical Androgen/Psychosis Associated with Synthetic Cannabinoid Agonists/Drug-Induced Yawning Cardiovascular Medications and Risk of Cancer
|
Joel, Shuster |
|
2011 |
|
12 |
p. 928-933 |
artikel |
34 |
Data Supporting the Use of Prescription Medications for Off-Label Indications
|
Baker, Danial E. |
|
2008 |
|
12 |
p. 956-957 |
artikel |
35 |
Delayed-Onset Neutropenia Associated with Divalproex Sodium; Acute Psychosis Induced by Clarithromycin; Acute Phase Reaction with Ibandronate; Duloxetine-Associated Tachycardia; Hepatotoxicity with Valerian; Serotonin Syndrome with a Single Dose of Buprenorphine/Naloxone
|
Shuster, Joel |
|
2008 |
|
12 |
p. 965-968 |
artikel |
36 |
Denileukin Diftitox and Valrubicin
|
Solimando, Dominic A. |
|
1999 |
|
12 |
p. 1381-1385 |
artikel |
37 |
Development and Implementation of a Pharmacy Fall Prevention Program
|
Beasley, Burl |
|
2009 |
|
12 |
p. 1095-1102 |
artikel |
38 |
Disease State Organization Web Sites
|
Flory, Stefanie M. |
|
1999 |
|
12 |
p. 1457-1460 |
artikel |
39 |
Don't Lose Track of Orders during Clarification Never Prescribe Leucovorin Calcium as “Folinic Acid” Confusion Mounting over Drug Name Suffixes Fellowship in Medication Safety
|
Cohen, Michael R. |
|
2003 |
|
12 |
p. 1120-1122 |
artikel |
40 |
Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC Followed by D) in the Treatment of Breast Cancer
|
Waddell, J. Aubrey |
|
2006 |
|
12 |
p. 1156-1163 |
artikel |
41 |
Dronedarone
|
Cada, Dennis J. |
|
2009 |
|
12 |
p. 1115-1123 |
artikel |
42 |
Drug-Induced Pulmonary Disease Home Diagnostics Basic Bibliographies Index
|
|
|
2001 |
|
12 |
p. 1296-1300 |
artikel |
43 |
Drug Monographs: Carfilzomib and Pertuzumab
|
Butler, Taylor W. |
|
2012 |
|
12 |
p. 920-923 |
artikel |
44 |
Drug Shortages: Process for Evaluating Impact on Patient Safety
|
Elyse, A. MacDonald |
|
2011 |
|
12 |
p. 943-951 |
artikel |
45 |
Eculizumab and Temsirolimus
|
Worley, Katherine B. |
|
2007 |
|
12 |
p. 1111-1114 |
artikel |
46 |
Effects of an Automated Drug Dispensing System on Medication Adverse Event Occurrences and Cost Containment at SAMSO
|
Dib, Jean G. |
|
2006 |
|
12 |
p. 1180-1185 |
artikel |
47 |
Emtricitabine
|
Cada, Dennis J. |
|
2003 |
|
12 |
p. 1151-1160 |
artikel |
48 |
Epirubicin, Cisplatin, and Fluorouracil (ECF) Regimen
|
Solimando, Dominic A. |
|
2009 |
|
12 |
p. 1072-1081 |
artikel |
49 |
Essential Information Appliance Skills for Pharmacists
|
Felkey, Bill G. |
|
2009 |
|
12 |
p. 1131-1132 |
artikel |
50 |
Evaluating Personal Health Record (PHR) Options for Accountable Care Organizations (ACOs)
|
Felkey, Bill G. |
|
2010 |
|
12 |
p. 951-952 |
artikel |
51 |
Expert Witnesses Should Lecture to Pharmacy Students
|
Davis, Neil M. |
|
2000 |
|
12 |
p. 1263 |
artikel |
52 |
Fever; Hospice and Palliative Care
|
Generali, Joyce A. |
|
2002 |
|
12 |
p. 1351-1368 |
artikel |
53 |
Fluorouracil, Doxorubicin, and Methotrexate (FAMTX) Regimen for Advanced Gastric Cancer
|
Waddell, J. Aubrey |
|
2005 |
|
12 |
p. 1036-1041 |
artikel |
54 |
Frequency of Nephrotoxicity with Vancomycin and Aminoglycoside Antibiotic Therapy
|
Hailemeskel, Bisrat |
|
1999 |
|
12 |
p. 1417-1420 |
artikel |
55 |
Fulvestrant; Oxaliplatin
|
Solimando, Dominic A. |
|
2002 |
|
12 |
p. 1282-1288 |
artikel |
56 |
Gabapentin: Cholestatic Pruritis
|
Generali, Joyce A. |
|
2009 |
|
12 |
p. 1086-1087 |
artikel |
57 |
Glimepiride-Induced Hypoglycemia with Ciprofloxacin, Metronidazole, and Acute Kidney Injury
|
Covvey, Jordan R. |
|
2010 |
|
12 |
p. 934-938 |
artikel |
58 |
Glycemic Control during Critical Illness: Tight or Not?
|
Dickerson, Roland N. |
|
2009 |
|
12 |
p. 1142-1148 |
artikel |
59 |
Glycopyrrolate Oral Solution
|
Cada, Dennis J. |
|
2010 |
|
12 |
p. 939-943 |
artikel |
60 |
Hemorrhagic Stroke Associated with Mixed Amphetamine Salts: Acyclovir-Induced Immune Thrombocytopenia: Recall Pneumonitis during Treatment with Sunitinib: Coagulopathy Caused by Cephradine-Induced Factor V Inhibition: Psoriasis Caused by Certolizumab Pegol: Excellent Reviews: Glucocorticoids and Increased Mortality in Hospitalized Patients with C. difficile-Associated Disease; Drug-Induced Osteoporosis; Adverse Drug Reactions (Part 1)
|
Shuster, Joel |
|
2010 |
|
12 |
p. 901-905 |
artikel |
61 |
Heparin-Induced Thrombocytopenia—Delayed Onset Neurotoxicity with a Fluoroquinolone Anaphylaxis with Ondansetron Delirium Associated with H2-Receptor Antagonists Topiramate-Induced Depression
|
Shuster, Joel |
|
2001 |
|
12 |
p. 1235-1241 |
artikel |
62 |
Hormone Replacement Therapy and Cardiovascular Risk
|
Howard, Patricia A. |
|
2002 |
|
12 |
p. 1269-1281 |
artikel |
63 |
Hospital Pharmacy 2008 Peer Reviewers
|
|
|
2008 |
|
12 |
p. 958 |
artikel |
64 |
Hospital Pharmacy Transition
|
Cada, Dennis J. |
|
2009 |
|
12 |
p. 1053 |
artikel |
65 |
How to Explain Vaccines to Children and other Inquisitive People
|
Grabenstein, John D. |
|
1999 |
|
12 |
p. 1421-1438 |
artikel |
66 |
Human Resources Management for the Pharmacy Director
|
Weber, Robert J. |
|
2006 |
|
12 |
p. 1206-1211 |
artikel |
67 |
Hyponatremia in Neurosurgical Patients: Syndrome of Inappropriate Antidiuretic Hormone or Cerebral Salt Wasting Syndrome?
|
Dickerson, Roland N. |
|
2002 |
|
12 |
p. 1336-1342 |
artikel |
68 |
Identification and Prevention of Antiretroviral Medication Errors at an Academic Medical Center
|
Horace, Alexis E |
|
2010 |
|
12 |
p. 927-933 |
artikel |
69 |
Impact of Medication Reconciliation on Medication Error Rates in Community Hospital Cardiac Care Units
|
Benson, John M. |
|
2012 |
|
12 |
p. 927-932 |
artikel |
70 |
Impact of Pharmacy-Generated Recommendations on Antibiotic Therapy in a Community Hospital
|
Steinberg, Jennifer G. |
|
2008 |
|
12 |
p. 988-993 |
artikel |
71 |
Impact of the Family and Medical Leave Act on Hospital Pharmacy Practice Management
|
Monk-Tutor, M. R. |
|
2001 |
|
12 |
p. 1245-1254 |
artikel |
72 |
Implementation and Outcome Assessment of an Inpatient Antimicrobial Stewardship Program
|
Hagert, Brandie L. |
|
2012 |
|
12 |
p. 939-945 |
artikel |
73 |
Implementing a Bar-Code Medication Administration System
|
Weber, Robert J. |
|
2008 |
|
12 |
p. 1016-1022 |
artikel |
74 |
Implementing a Standardized HIV Antiretroviral Order Form May Reduce Medication Errors
|
Faragon, John J. |
|
2003 |
|
12 |
p. 1187-1192 |
artikel |
75 |
Implementing PDA Initiatives in Health System Pharmacies
|
Liang, Huigang |
|
2002 |
|
12 |
p. 1348-1350 |
artikel |
76 |
Industry Relationships and the Pharmacy Director: Striking the Right Balance
|
Mulvanity, Meredith |
|
2009 |
|
12 |
p. 1136-1141 |
artikel |
77 |
In Memoriam: Lou Lasagna
|
Cada, Dennis |
|
2003 |
|
12 |
p. 1118-1119 |
artikel |
78 |
Insulin Detemir
|
Cada, Dennis J. |
|
2005 |
|
12 |
p. 1062-1074 |
artikel |
79 |
Insulin Pen Misuse by Patient; Diluent Vial Looks like Drug Vial; Full Content cannot be Withdrawn from Istodax Vial; Patients May Fail to Remove Used Fentanyl Patches
|
Cohen, Michael R. |
|
2012 |
|
12 |
p. 912-914 |
artikel |
80 |
Interesting Developments in the PDA Operating System World
|
Fox, Brent I. |
|
2005 |
|
12 |
p. 1088-1090 |
artikel |
81 |
Interferon Beta—Induced Panniculitis Mimicking Acute Appendicitis; Acute Methotrexate Neurotoxicity with Associated Choreiform Movements; Chorea Associated with Gabapentin Use; Acute Interstitial Nephritis Associated with Linezolid; Atypical Neuroleptic Malignant Syndrome with Quetiapine; Hypersensitivity Reactions to Generic Drugs with Soybean Oil
|
Shuster, Joel |
|
2009 |
|
12 |
p. 1066-1069 |
artikel |
82 |
Inter-Rater Reliability in the Evaluation of a Thrombosis Risk Assessment Tool
|
Nygaard, Angela |
|
2009 |
|
12 |
p. 1089-1094 |
artikel |
83 |
In the Maelstrom: Managing Urgent National Safety Data
|
Generali, Joyce A. |
|
2012 |
|
12 |
p. 910-911 |
artikel |
84 |
Intravesical Gemcitabine for Superficial Bladder Carcinoma
|
Waddell, J. Aubrey |
|
2004 |
|
12 |
p. 1153-1154 |
artikel |
85 |
Irinotecan and Cisplatin (IP) Regimen
|
Waddell, J. Aubrey |
|
2008 |
|
12 |
p. 970-975 |
artikel |
86 |
Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
|
Mayer, Michael I. |
|
2000 |
|
12 |
p. 1274-1279 |
artikel |
87 |
Is it Finally Time to Address Prevention and Wellness?
|
Felkey, Bill G. |
|
2012 |
|
12 |
p. 969-970 |
artikel |
88 |
Is Medical Care Obsolete?
|
Lawrence, David |
|
1999 |
|
12 |
p. 1395-1400 |
artikel |
89 |
Lack of Standard Dosing Methods Contribute to IV Errors Talc Misadministered IV
|
Cohen, Michael R. |
|
2007 |
|
12 |
p. 1100-1102 |
artikel |
90 |
Letter to the Editor
|
Daly, Joseph M. |
|
2010 |
|
12 |
p. 897 |
artikel |
91 |
Levobupivacaine
|
Cada, Dennis J. |
|
1999 |
|
12 |
p. 1441-1453 |
artikel |
92 |
Light-Sensitive Oral Prescription Drugs
|
King, Allison R. |
|
2009 |
|
12 |
p. 1112-1114 |
artikel |
93 |
Medicare Non-Payment for Selected Medical Errors and Nosocomial Infection
|
Cada, Dennis |
|
2007 |
|
12 |
p. 1098 |
artikel |
94 |
Medication Errors Associated with Levothyroxine Products
|
Pamer, Carol A. |
|
2000 |
|
12 |
p. 1280-1286 |
artikel |
95 |
Medication Reconciliation and Community Pharmacy; Drug Name Alerts; Another ADC Stocking Error; Unsafe Marketing Practice
|
Cohen, Michael R. |
|
2006 |
|
12 |
p. 1148-1150 |
artikel |
96 |
Medication Safety in the Pediatric OR
|
Levine, Stuart |
|
2002 |
|
12 |
p. 1279-1281 |
artikel |
97 |
Metformin: Weight Loss (Antipsychotic–Induced Weight Gain)
|
Generali, Joyce |
|
2002 |
|
12 |
p. 1289-1294 |
artikel |
98 |
Methylphenidate Extended-Release Tablets
|
Cada, Dennis J. |
|
2000 |
|
12 |
p. 1319-1327 |
artikel |
99 |
Methylphenidate Extended-Release Tablets
|
Cada, Dennis J. |
|
2000 |
|
12 |
p. 1319-1327 |
artikel |
100 |
Metronidazole and Metformin: Prone to Mix-ups: Soy Allergy?: Save Lives: Improve the Pneumococcal Vaccine Administration Rate: Inefficient Screening Process: Omitted Vaccine Administration: Flammability of Ethyl Chloride: Current Nonproprietary Drug Names under Consideration by United States Adopted Names Council
|
Cohen, Michael R. |
|
2004 |
|
12 |
p. 1140-1146 |
artikel |
101 |
Misprogramming Patient-Controlled Analgesia Concentration Leads to Dosing Errors; Communicate Alteplase Dose and Indication; Do Not Use Empty Prelabeled Syringes/Bowls
|
Cohen, Michael R. |
|
2008 |
|
12 |
p. 960-963 |
artikel |
102 |
Modafinil: Multiple Sclerosis-Related Fatigue
|
Generali, Joyce |
|
2005 |
|
12 |
p. 1044-1050 |
artikel |
103 |
Multifactorial Approach to Fall Reduction in the Acute Care Setting: A Role for Pharmacists
|
Russett, Flint |
|
2006 |
|
12 |
p. 1146-1147 |
artikel |
104 |
Multifunction PDAs: Digital Imaging
|
Fox, Brent I. |
|
2004 |
|
12 |
p. 1206-1207 |
artikel |
105 |
National Health Care Expenditures Remain Constant
|
Wilson, C. Nick |
|
1999 |
|
12 |
p. 1377-1380 |
artikel |
106 |
Nebulized Lidocaine Solution for Control of Intractable Cough in a Patient with Metastatic Malignant Melanoma
|
Burns, Kevin E. |
|
2000 |
|
12 |
p. 1349-1352 |
artikel |
107 |
New Antifungal as a Potential Cause of Severe Thrombocytopenia: Pancreatitis Due to ACE Inhibitor: Recurrent Hepatitis Due to Cetirizine: Long-Term Cardiovascular Risks Associated with Protease Inhibitors: Pure Red Cell Aplasia and Epoetin Therapy: Pure Red Cell Aplasia Redux: Interferon Therapy: Excellent Drug Reaction Reviews
|
Shuster, Joel |
|
2004 |
|
12 |
p. 1148-1153 |
artikel |
108 |
New Drugs Approved by the FDA Agents Pending FDA Approval Supplemental Applications Filed by Manufacturer Significant Labeling Changes
|
Baker, Danial E. |
|
2007 |
|
12 |
p. 1156-1162 |
artikel |
109 |
New Drugs Approved by the FDA;New Dosage Forms and Indications;Agents Pending FDA Approval;Labeling Changes Related to Safety
|
Baker, Danial E. |
|
2002 |
|
12 |
p. 1318-1335 |
artikel |
110 |
New Drugs Approved by the FDA New Dosage Forms and Indications Agents Pending FDA Approval Labeling Changes Related to Safety
|
Baker, Danial E. |
|
2001 |
|
12 |
p. 1278-1289 |
artikel |
111 |
New Drugs Approved by the FDA; New Dosage Forms and Indications; Agents Pending FDA Approval; Major Labeling Changes
|
Baker, Danial E. |
|
2000 |
|
12 |
p. 1328-1341 |
artikel |
112 |
New Drugs Approved by the FDA New Dosage Forms and Indications Agents Pending FDA Approval Major Labeling Changes
|
Baker, Danial E. |
|
1999 |
|
12 |
p. 1462-1474 |
artikel |
113 |
New Drugs Approved by the FDA; New Dosage Forms and Indications; Agents Pending FDA Approval; Significant Labeling Changes
|
Baker, Danial E. |
|
2006 |
|
12 |
p. 1198-1203 |
artikel |
114 |
New Drugs Approved by the FDA: New Dosage Forms and Indications: Agents Pending FDA Approval: Significant Labeling Changes
|
Baker, Danial E. |
|
2005 |
|
12 |
p. 1075-1080 |
artikel |
115 |
New Drugs Approved by the FDA: New Dosage Forms and Indications: Agents Pending FDA Approval: Significant Labeling Changes Related to Safety
|
Baker, Danial E. |
|
2004 |
|
12 |
p. 1192-1203 |
artikel |
116 |
New Drugs Approved by the FDA New Dosage Forms and Indications Agents Pending FDA Approval Significant Labeling Changes Related to Safety
|
Baker, Danial E. |
|
2003 |
|
12 |
p. 1163-1174 |
artikel |
117 |
New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; New Drug Applications Filed by Manufacturer; Significant Labeling Changes or “Dear Health Care Professional” Letters Related to Safety
|
Baker, Danial E. |
|
2008 |
|
12 |
p. 1011-1013 |
artikel |
118 |
New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; New Drug/Biologics License Applications Filed by Manufacturer; Significant Labeling Changes or “Dear Health Care Professional” Letters Related to Safety
|
Baker, Danial E. |
|
2009 |
|
12 |
p. 1124-1129 |
artikel |
119 |
New Drugs Approved by the FDA: New Dosage Forms and Indications Approved by the FDA: Agents Pending FDA Approval: New Drug/Biologics License Applications Filed by Manufacturer: Significant Labeling Changes or “Dear Health Professional” Letters Related to Safety
|
Baker, Danial E. |
|
2010 |
|
12 |
p. 947-950 |
artikel |
120 |
New Drugs Approved by the FDA/New Dosage Forms and Indications Approved by the FDA/New Drug/Biologics License Applications Filed by Manufacturer/Significant Labeling Changes or “Dear Health Professional” Letters Related to Safety
|
Danial, E. Baker |
|
2011 |
|
12 |
p. 975-980 |
artikel |
121 |
New Hospital Pharmacy Feature: Critical Care Therapeutics
|
Cada, Dennis |
|
2001 |
|
12 |
p. 1231 |
artikel |
122 |
Nitroglycerin (Ointment): Low Bone Density or Osteoporosis in Postmenopausal Women
|
Joyce, A. Generali |
|
2011 |
|
12 |
p. 938-942 |
artikel |
123 |
Nitroglycerin (Topical): Raynaud Phenomenon
|
Generali, Joyce A. |
|
2008 |
|
12 |
p. 980-981 |
artikel |
124 |
Nitroglycerin (Transdermal): Raynaud Phenomenon
|
Generali, Joyce A. |
|
2012 |
|
12 |
p. 924-926 |
artikel |
125 |
No Extraneous Information, Please: Adding Drug to Hanging IV Bag Poses Many Risks: Doribax-Zovirax Name Confusion: Ambiguous Directions, Wrong Assumption by Patient
|
Cohen, Michael R. |
|
2010 |
|
12 |
p. 898-905 |
artikel |
126 |
Octreotide: Dumping Syndrome
|
Gilchrist, Brad |
|
2009 |
|
12 |
p. 1083-1085 |
artikel |
127 |
Ondansetron: Postanesthetic Shivering
|
Generali, Joyce |
|
2006 |
|
12 |
p. 1169-1172 |
artikel |
128 |
Oxcarbazepine in Mood Disorders
|
Norton, John |
|
2001 |
|
12 |
p. 1254-1256 |
artikel |
129 |
Pentoxifylline: Aphthous Stomatitis
|
Generali, Joyce |
|
2007 |
|
12 |
p. 1117-1121 |
artikel |
130 |
Personality Disorders Pharmacy Technicians
|
Generali, Joyce A. |
|
2003 |
|
12 |
p. 1183-1186 |
artikel |
131 |
Pharmacist Intervention Documentation in US Health Care Systems
|
Kim, Youngmee |
|
2003 |
|
12 |
p. 1141-1147 |
artikel |
132 |
Pharmacist-Managed Anemia Program in an Outpatient Hemodialysis Population
|
Walton, Ted |
|
2005 |
|
12 |
p. 1051-1056 |
artikel |
133 |
Pharmacists' Right to Refuse to Dispense Prescriptions Based on Moral Grounds: A Summary of State Laws and Regulations
|
Hopkins, Denise |
|
2006 |
|
12 |
p. 1176-1179 |
artikel |
134 |
Pharmacy and Laboratory Collaboration: Response to the Editor
|
Erica, E. Reed |
|
2011 |
|
12 |
p. 920-921 |
artikel |
135 |
Pharmacy Issues: Clinical Screenings and Discharge Prescriptions
|
Miller, Alicia S. |
|
2001 |
|
12 |
p. 1290-1293 |
artikel |
136 |
Pharmacy Issues: Drug Routes, Dosage Forms, and Drug Frequencies
|
Miller, Alicia S. |
|
2000 |
|
12 |
p. 1342-1344 |
artikel |
137 |
Phentermine/Topiramate Extended Release
|
Cada, Dennis J. |
|
2012 |
|
12 |
p. 950-958 |
artikel |
138 |
Pneumocystis jiroveci Pneumonia in an Infant Treated with Oral Steroids All-Trans Retinoic Acid as a Cause of Respiratory Failure Dronabinol-Induced Gynecomastia Neutrophilic Dermatitis Seen with Bortezomib Unfavorable Smell with a Selective Serotonin Reuptake Inhibitor Aloe Vera-Induced Hepatitis Pulmonary Sarcoidosis Attributed to Etanercept Serious Adverse Drug Events Reported to the Food and Drug Administration
|
Shuster, Joel |
|
2007 |
|
12 |
p. 1104-1108 |
artikel |
139 |
Preventing Adverse Drug Events with Rounding Pharmacists Adverse Drug Events Involving COX-2 Inhibitors Psoriasis Associated with Rofecoxib Adverse Events Seen with Ribavirn Therapy for SARS Immediate Hypersensitivity to Clavulanic Acid Thrombocytopenia with Vancomycin
|
Shuster, Joel |
|
2003 |
|
12 |
p. 1122-1125 |
artikel |
140 |
Preventing Magnesium Toxicity in Obstetrics: Coumadin–Cardura Mix-Ups
|
Cohen, Michael R. |
|
2005 |
|
12 |
p. 1028-1031 |
artikel |
141 |
Product Selection and Pharmaceutical Comparison of Two Anti-D Immune Globulins
|
Siegel, Jerry |
|
2008 |
|
12 |
p. 994-998 |
artikel |
142 |
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
|
Cada, Dennis J. |
|
2006 |
|
12 |
p. 1185-1195 |
artikel |
143 |
QuarterWatch Signals for Two Newly Approved Drugs: Dabigatran and Dalfampridine/Include Purpose on Rx/Use of Two Pumps Allows Bypass of Drug Library/Anesthesia Patient Safety Foundation Tackles Postoperative Opioid Monitoring/Lilly Updates Humulin R U-500 Label
|
Michael, R. Cohen |
|
2011 |
|
12 |
p. 922-927 |
artikel |
144 |
Questions and Answers about the 2004 Medication Management Standards
|
Rich, Darryl S. |
|
2003 |
|
12 |
p. 1175-1179 |
artikel |
145 |
Questions and Answers from the F.I.X.
|
Cada, Dennis J. |
|
1999 |
|
12 |
p. 1392-1394 |
artikel |
146 |
Questions and Answers from the F.I.X. Helpful Recent Releases Stability of Split Olanzapine Tablets Calculating Creatinine Clearance Enoxaparin in Obesity
|
Cada, Dennis J. |
|
2001 |
|
12 |
p. 1242-1245 |
artikel |
147 |
Questions and Answers from the F.I.X.; • New Guidelines; •Prochlorperazine/Diphenhydramine Compatibility; • Heparin-Induced Thrombocytopenia in Dialysis Patients; •Subcutaneous Administration of Asparaginase; •Antimicrobial Dosing in Obesity
|
Cada, Dennis J. |
|
2000 |
|
12 |
p. 1293-1296 |
artikel |
148 |
Quinine-Quinidine Mix-Ups Still Happen; APSF Offers Recommendations for Safe Postop Opioid Administration and Monitoring
|
Cohen, Michael R. |
|
2009 |
|
12 |
p. 1062-1064 |
artikel |
149 |
Ranolazine-Induced Severe Bladder Hypotonia; Fatal Varicella-Zoster Vasculopathy Associated with Adalimumab Therapy; SIADH Induced by a Single Dose of Cyclophosphamide; Tetany, Hypomagnesemia, and Proton Pump Inhibitors; Unnecessary Surgery for Acute Abdomen Caused by ACE Inhibitor Use; Atazanavir-Associated Renal Stones and Biliary Stones; Drug-Induced Hallucinations Associated with Amantadine and Tizanidine
|
Shuster, Joel |
|
2012 |
|
12 |
p. 915-918 |
artikel |
150 |
Recent Publications on Medications and Pharmacy
|
Russett, Flint |
|
2010 |
|
12 |
p. 953-955 |
artikel |
151 |
Recent Publications on Medications and Pharmacy
|
Generali, Joyce |
|
2005 |
|
12 |
p. 1091-1093 |
artikel |
152 |
Recent Publications on Medications and Pharmacy
|
Sterling, Jacyntha A. |
|
2009 |
|
12 |
p. 1149-1155 |
artikel |
153 |
Recent Publications on Medications and Pharmacy
|
Sterling, Jacyntha |
|
2007 |
|
12 |
p. 1172-1175 |
artikel |
154 |
Recent Publications on Medications and Pharmacy
|
Flint, Russett |
|
2011 |
|
12 |
p. 990-993 |
artikel |
155 |
Recent Publications on Medications and Pharmacy
|
Sterling, Jacyntha A. |
|
2008 |
|
12 |
p. 1024-1029 |
artikel |
156 |
Recent Publications on Medications and Pharmacy
|
Russett, Flint |
|
2012 |
|
12 |
p. 971-973 |
artikel |
157 |
Review of Intravenous Selenium Infusions for the Critically III Patient
|
Haygood, Rebecca J. |
|
2012 |
|
12 |
p. 933-938 |
artikel |
158 |
Rivaroxaban
|
Dennis, J. Cada |
|
2011 |
|
12 |
p. 960-970 |
artikel |
159 |
Septra RS?
|
Dunn, Eddie B. |
|
1999 |
|
12 |
p. 1478-1480 |
artikel |
160 |
Side Effects of Vaccination: A Consumer's Guide to Cause and Effect
|
Grabenstein, John D. |
|
2000 |
|
12 |
p. 1308-1318 |
artikel |
161 |
Side Effects of Vaccination: A Consumer's Guide to Cause and Effect
|
Grabenstein, John D. |
|
2000 |
|
12 |
p. 1308-1318 |
artikel |
162 |
Sildenafil (Topical): Anal Fissures
|
Generali, Joyce |
|
2004 |
|
12 |
p. 1160-1162 |
artikel |
163 |
Stanford V Regimen for Hodgkin Lymphoma
|
Yarbro, Laura M. |
|
2010 |
|
12 |
p. 906-913 |
artikel |
164 |
Strategies for Effective Medication Use Evaluations
|
Greer, Nickie D. |
|
2007 |
|
12 |
p. 1163-1166 |
artikel |
165 |
Strategies for Staff Recognition
|
Scott, M. Mark |
|
2011 |
|
12 |
p. 984-989 |
artikel |
166 |
Survey of Alternative Supplement Use within a Hospitalized Population
|
Leady, Michelle A. |
|
2002 |
|
12 |
p. 1295-1300 |
artikel |
167 |
Survey of Preoperative Patients' Use of Herbal Products and Other Selected Dietary Supplements
|
Meyer, Tricia A. |
|
2002 |
|
12 |
p. 1301-1306 |
artikel |
168 |
Tamiflu: Drug Hoarding vs Public Stockpiling
|
Baker, Danial E. |
|
2005 |
|
12 |
p. 1027 |
artikel |
169 |
The Biotechnology Revolution: A Primer for Pharmacists
|
Tolstoi, Linda G. |
|
1999 |
|
12 |
p. 1401-1408 |
artikel |
170 |
The Hospital Pharmacist as an Expert Witness
|
Van Dusen, Virgil |
|
2000 |
|
12 |
p. 1296-1303 |
artikel |
171 |
The Impact of Hospital Pharmacist and Technician Teams on Medication-Process Quality and Nurse Satisfaction
|
Weber, Robert J. |
|
2004 |
|
12 |
p. 1169-1176 |
artikel |
172 |
The Implementation Process (Part 3)
|
Miller, Alicia S. |
|
2002 |
|
12 |
p. 1343-1347 |
artikel |
173 |
The Information Appliance of Choice
|
Bill, G. Felkey |
|
2011 |
|
12 |
p. 982-983 |
artikel |
174 |
The Life and Times of an e-Prescription
|
George, A. Robinson |
|
2011 |
|
12 |
p. 956-959 |
artikel |
175 |
The Silver Lining: Turning Hardship into Opportunity
|
O'neal, Brian C. |
|
2010 |
|
12 |
p. 896-897 |
artikel |
176 |
The Use of Colistin in Multidrug-Resistant Infections
|
Zapantis, Antonia |
|
2007 |
|
12 |
p. 1127-1138 |
artikel |
177 |
Thrombocytopenia Caused by Heparin Flushes When are Drug-Induced Rises in Plasma Creatinine Not a Problem? Procainamide-Induced Psychosis Valproate and Hyperammonemia
|
Shuster, Joel |
|
1999 |
|
12 |
p. 1385-1391 |
artikel |
178 |
Topiramate: Binge Eating Disorder
|
Generali, Joyce |
|
2003 |
|
12 |
p. 1133-1140 |
artikel |
179 |
Treating Veterans for Helicobacter Pylori Infection: Retrospective Evaluation of Long-term Outcomes
|
Segarra-Newnham, Marisel |
|
2004 |
|
12 |
p. 1165-1169 |
artikel |
180 |
Two More Drugs Associated with SIADH;Infliximab-Induced Systemic Lupus Erythematosus;Massive Tendon Xanthomas Associated with HAART;Ischemic Colitis with Sumatriptan;Fatal Hepatic Necrosis Due to Lamotrigine;Antidepressant-Induced Sexual Dysfunction
|
Shuster, Joel |
|
2002 |
|
12 |
p. 1262-1266 |
artikel |
181 |
Upcoming Hospital Pharmacy Feature: “Off-Label Drug Uses”
|
Cada, Dennis J. |
|
2000 |
|
12 |
p. 1264 |
artikel |
182 |
Use Your Preadmission Process to Enhance Safety;Beware of Drug Names that End in the Letter “L”; It Doesn't Pay to Play the Percentages
|
Cohen, Michael R. |
|
2002 |
|
12 |
p. 1257-1261 |
artikel |
183 |
Using Nitrogen Balance in Clinical Practice
|
Dickerson, Roland N. |
|
2005 |
|
12 |
p. 1081-1087 |
artikel |
184 |
Vision Side Effects with Erectile Dysfunction Agents: Paradoxical Bronchoconstriction with Albuterol: Thalidomide-Associated Thrombocytopenia: Can Antibiotic Treatment of Acne Cause Upper Respiratory Infections?: Cell Phone Causes Interference with Infusion Pump: Headaches Associated with Oral Contraceptives: Cardiotoxicity with Cancer Chemotherapy: Atypical Antipsychotic Agents and Parkinsonism
|
Shuster, Joel |
|
2005 |
|
12 |
p. 1032-1087 |
artikel |
185 |
Ziprasidone Mesylate for Injection
|
Cada, Dennis J. |
|
2002 |
|
12 |
p. 1307-1317 |
artikel |
186 |
Zoledronic Acid for Injection
|
Cada, Dennis J. |
|
2001 |
|
12 |
p. 1-10 |
artikel |
187 |
Zoledronic Acid vs Pamidronate for the Prevention of Hypercalcemia of Malignancy or Bone Metastases in Hospital Outpatients: Time Analysis and Economic Implications
|
Gammon, David C. |
|
2003 |
|
12 |
p. 1148-1150 |
artikel |